Wednesday, 4 November 2026
M
Meridian Globe
Live briefing
Fukushima tries to reinvent itself as hub for drones, robots and rockets— 日经 Nikkei AsiaJapan's Yamato targets 'leaner' delivery service in push for profit: president— 日经 Nikkei AsiaNew MUFG digital bank to forgo ATM cards in cybercrime safeguard— 日经 Nikkei AsiaJapan to bolster defenses with unified missile, artillery systems— 日经 Nikkei AsiaNTT to help Japanese companies update at-risk aging IT with AI— 日经 Nikkei Asia5 things to know about the US midterms and what they mean for Asia— 日经 Nikkei AsiaChina's cable-cutting threat reaches Taiwan and the Philippines— 日经 Nikkei AsiaVienna entrepreneur takes leaders on lux train to China to foster ties— 日经 Nikkei AsiaFukushima tries to reinvent itself as hub for drones, robots and rockets— 日经 Nikkei AsiaJapan's Yamato targets 'leaner' delivery service in push for profit: president— 日经 Nikkei AsiaNew MUFG digital bank to forgo ATM cards in cybercrime safeguard— 日经 Nikkei AsiaJapan to bolster defenses with unified missile, artillery systems— 日经 Nikkei AsiaNTT to help Japanese companies update at-risk aging IT with AI— 日经 Nikkei Asia5 things to know about the US midterms and what they mean for Asia— 日经 Nikkei AsiaChina's cable-cutting threat reaches Taiwan and the Philippines— 日经 Nikkei AsiaVienna entrepreneur takes leaders on lux train to China to foster ties— 日经 Nikkei Asia

Stakeholder-informed use cases and target product characteristics for vaccines and therapeutics for Nipah virus disease

Source Nature 生命科学13h ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Science
Region
Global
Language
English
Item ID
science-88954da4

Comments 0 comments

No comments yet. Be the first.

Stakeholder-informed use cases and target product characteristics for vaccines and therapeutics for Nipah virus disease · Meridian Globe